ClinicalTrials.gg
RecruitingNCT06907589OLIMPIAUpdated Apr 2, 2025

A Novel Accessible and Widespread Healthcare Service Model Based on Technology Innovation for Objective (Early) Diagnosis and Therapeutic Monitoring of Parkinson's Disease Promoting Continuity of Care

An interventional study of Motor Data Analysis in Parkinson Disease and Healthy Adult, sponsored by Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna. Recruiting at 5 sites in Italy. Open to participants aged 50 Years to 80 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-02.

Sponsored by Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna · Not applicable, Interventional, and Device feasibility

How we know

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as recruiting.
  • Registered 10 months after the study started (first participant enrolled May 2024, registered Mar 2025).
  • Started May 2024; still recruiting 2 years 6 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
250
Allocation
Not applicable
Ages
50 Years to 80 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 348 studies in Parkinson Disease with a site in Italy — 89 open to participants now, 108 under way, 4 of them phase 3. Parkinson Disease · Italy.

Planned enrollment
58th of 244
250 · median 82
Started
2024
with 13 others
No phase
146 of 348
41 open now
Primary completion
2026-01
later than 31 of 107 live
Registered
302nd of 348
by date

Among the 348 studies in Parkinson Disease with a site in Italy, this one is the 58th largest by planned enrollment of the 244 interventional ones that give a count, is one of 14 that started in 2024, is one of 146 with no phase, reaches primary completion later than 31 of the 107 other live ones, and was the 302nd registered.

Parkinson Disease

4,583 studies on the registry are indexed under Parkinson Disease; 1,086 are open to participants now.

Browse Parkinson Disease studies →

Open to participants now

89 of the 348 studies in Parkinson Disease with a site in Italy are open now. Recruiting first, the newest first:

84 more — sign in →

All 89 open studies →

A study can be open while its sites in Italy have not opened yet or have stopped. Only those recruiting at a site in Italy →

Who these studies take

Of the 752 Parkinson Disease studies recruiting now, 314 (42%) set no upper age limit and 127 (17%) stop at 75 or younger; 64 take children under 18; 189 take healthy volunteers.

This study: 50 Years to 80 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 348 studies in Parkinson Disease with a site in Italy, or all of them as a file.
02

Study summary

The present study aims to use the SensMode System - a system composed of wearable devices for upper and lower limb movement analysis and electronic device for data acquisition and processing - on healthy subjects, subjects with idiopathic hyposmia, patients with Parkinson's disease, and subjects with de-novo drug-naïve extrapyramidal syndrome. The purpose is to identify normative data of objective motor measures obtained with such a system, as well as to increase knowledge about the potential contribution such a solution can make to the preclinical diagnosis of Parkinson's disease and the management of patients with this disease.

03

Conditions studied

  • Parkinson Disease
  • Healthy Adult

Browse trials for

Keywords

  • parkinson's disease
  • wearable sensors
  • motor data
04

Who can participate

Ages eligible
50 Years to 80 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  1. Healthy subjects - Inclusion Criteria:

    • Adult subjects, both sexes, aged 50-80 years old
    • score >= 24 absence of olfactory deficit detected on IOIT olfactory test (22). Age class 50-59 years: normal with score \<=5; age class 60-69 years: normal with score \<=6; age class > 70 years: normal with score \<=7
    • absence of neurological diseases
    • absence of functional deficit in the sphere of locomotion as a result of traumatic injury or from other cause to the upper and/or lower limbs and/or pelvis and/or spine
    • expression of to participate in the study
  2. Subjects with Parkinson's disease -- Inclusion criteria:

    • adult subjects, both sexes, 50-80 years of age
    • MMSE score >= 24
    • subjects with Parkinson's disease in the absence of motor fluctuations and dyskinesias, or subjects with Parkinson's disease with mild motor fluctuations throughout the day, but to be examined in the ON phase and in the absence of dyskinesias
    • Hoehn and Yahr stage 1, 2, 3
    • absence of functional deficit in the sphere of locomotion as a result of traumatic injury or from other cause to the upper and/or lower limbs and/or pelvis and/or spine
    • expression of informed consent to participate in the study

Exclusion criteria

Exclusion Criteria:

  1. Healthy subjects - Exclusion criteria:

    • denial of to participate in the study
    • Presence of olfactory deficit detected on IOIT olfactory test. Age class 50-59 years: hyposmia with score >=6; age class 60-69 years: hyposmia with score >=7; age class > 70 years: hyposmia with score >=8
    • body weight greater than 120 kg
    • insufficient degree of cooperation
    • malignant neoplasm in progress or with negative follow-up of less than 6 years
    • structured joint stiffness in the upper and/or lower extremities preventing proper execution of movements
    • paresis and/or plegia of upper and/or lower limb muscle groups from both peripheral and central nerve injury
    • mono/multi/poly sensory and/or motor neuropathy
    • chronic inflammatory diseases with joint involvement of the upper and/or lower limbs
    • vertiginous syndromes in the acute phase
    • neurodegenerative diseases
    • fever
    • venous thrombosis
    • cardiovascular disorders or other acute or chronic conditions capable of affecting the proper performance of motor exercises
    • spinal or joint pain of various etiologies that may affect the performance of motor exercises
    • positive history of recurrent acute cervico-brachialgia and/or lumbosciatica
  2. Subjects with Parkinson's disease - Exclusion criteria:

    • Denial of informed consent to participate in the study
    • Hoenn and Yahr stage 4, 5
    • Patient who needs to use an aid (cane or walker) while walking or cannot walk unless aided by a person
    • body weight greater than 120 kg
    • insufficient degree of cooperation
    • malignant neoplasm in place or with negative follow-up of less than 6 years
    • structured joint stiffness in the upper and/or lower extremities that prevents proper execution of movements
    • paresis and/or plegia of upper and/or lower limb muscle groups from both peripheral and central nerve injury mono/multi/poly sensory and/or motor neuropathy
    • chronic inflammatory diseases with joint involvement of the upper and/or lower limbs
    • vertiginous syndromes in the acute phase
    • neurodegenerative diseases, excluding Parkinson's disease
    • fever
    • venous thrombosis
    • cardiovascular disorders or other acute or chronic conditions capable of affecting the proper performance of motor exercises
    • spinal or joint pain of various etiologies that may affect the performance of motor exercises
    • positive history of recurrent acute cervico-brachialgia and/or low back pain
Terms in these criteria, in plain language(2)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

MMSE and MoCA

Short tests of memory and thinking, each scored out of 30. Lower scores suggest more difficulty; criteria give a range, either to include people with memory problems or to leave them out.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Phase
Not applicable
Primary purpose
Device feasibility
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
250 participants (estimated)

Study arms

  • Experimental
    Motor Data Analysis for Healthy Subjects

    All subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement

    Device: Motor Data Analysis

  • Experimental
    Motor Data Analysis for patients with Parkinson's disease

    All subjects who are recruited in the study undergo sensors administration for motor analysis at the enrollement

    Device: Motor Data Analysis

Interventions

  • DeviceMotor Data Analysis

    The SensMode System includes wearable devices for upper and lower limb motion analysis. The upper limb device, SensHand, consists of 3 sensorized elements: 2 sensorized rings to be placed at the level of the distal phalanx of the thumb and forefinger of the hand and 1 sensorized wristband to be placed at the level of the distal portion of the forearm near the wrist. Each element of SensHand allows the acquisition of inertial data with respect to the biomechanics of the arm-forearm-wrist and the first three fingers of the hand, measuring the 3 components in space of linear acceleration, angular velocity, and magnetic field. The lower limb device, SensFoot, is a device that integrates the same electronic components as the bracelet and is placed in a plastic housing shaped like a small rectangular parallelepiped that is placed over the shoe.

06

What researchers measure

Primary outcomes

  1. Number of repetitions

    Number of repetitions in Finger Tapping task

    Time frame: at Enrollment (T0)

  2. Number of repetitions

    Number of repetitions in Thumb-ForeFinger Tapping task

    Time frame: at Enrollment (T0)

  3. Number of repetitions

    Number of repetitions in Opening/Closing task

    Time frame: at Enrollment (T0)

  4. Number of repetitions

    Number of repetitions in Pronosupination task

    Time frame: at Enrollment (T0)

  5. Number of repetitions

    Number of repetitions in Toe Tapping task

    Time frame: at Enrollment (T0)

  6. Number of repetitions

    Number of repetitions in Leg Agility task

    Time frame: at Enrollment (T0)

  7. Number of repetitions

    Number of repetitions in Heel Tapping task

    Time frame: at Enrollment (T0)

  8. Number of repetitions

    Number of repetitions in Heel-Toe Tapping task

    Time frame: at Enrollment (T0)

  9. Time to Stand Up

    Time to stand up from a chair

    Time frame: at Enrollment (T0)

  10. Gait Time

    Time to walk for 15 meters straight on

    Time frame: at Enrollment (T0)

  11. Rotation Time

    Time to perform a turning of 360°

    Time frame: at Enrollment (T0)

  12. Fundamental frequency of accelerometer signal

    Fundamental frequency of accelerometer signal for hands resting tremor task

    Time frame: At enrollment (T0)

  13. Fundamental frequency of accelerometer signal

    Fundamental frequency of accelerometer signal for feet resting tremor task

    Time frame: At enrollment (T0)

  14. Fundamental frequency of accelerometer signal

    Fundamental frequency of accelerometer signal for hands postural tremor task

    Time frame: At enrollment (T0)

  15. Fundamental frequency of accelerometer signal

    Fundamental frequency of accelerometer signal for hands kinetic tremor task

    Time frame: At enrollment (T0)

  16. Strides Number

    Number of strides to walk for 15 meters straight on

    Time frame: at Enrollment (T0)

07

Study locations

5 of 5 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started May 2024 (actual). Primary completion is estimated for Jan 2026, 20 months after the start.

Of 1,297 non-industry interventional studies with no phase under Parkinson Disease, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 11 and three quarters within 44. This study's planned 20 months is below that.

Counting every sponsor, half of 1,373 studies reached it within 25 months; a quarter within 11 and three quarters within 44.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 26, 2025
First posted
Apr 2, 2025
StartActual
May 13, 2024
Primary completionEst.
Jan 2026
CompletionEst.
Jan 8, 2026
Last update
Apr 2, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 2, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06907589
Lead sponsor
Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna
Responsible party
Filippo Cavallo (Associate Professor, Scuola Superiore di Studi Universitari e di Perfezionamento Sant'Anna) — Principal investigator
First posted
Apr 2, 2025
Start date
May 13, 2024
Primary completion
Jan 2026 (estimated)
Completion
Jan 8, 2026 (estimated)
Last update
Apr 2, 2025

Study contacts

Filippo Cavallo
Contact
filippo.cavallo@santannapisa.it
+390552758663
Erika Rovini
Contact
erika.rovini@unifi.it
+390553758663

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion